Why The Joint Corp.’s (JYNT) Stock Is Up 6.30%
As of Tuesday, June 30, The Joint Corp.’s JYNT share price has surged by 6.30%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Commentary & Analysis
Why The Joint Corp.’s (JYNT) Stock Is Down 5.93%
As of Thursday, June 25, The Joint Corp.’s JYNT share price has dipped by 5.93%, which has investors questioning if this is right time to buy.Michael Rose
Why The Joint Corp.’s (JYNT) Stock Is Up 5.37%
As of Wednesday, June 24, The Joint Corp.’s JYNT share price has surged by 5.37%, which has investors questioning if this is right time to sell.Jenna Brashear
What You Need to Know About The Joint Corp.'s Q2 Earnings
The Joint Corp.'s fiscal Q2 earnings report was released on Thursday, May 07. Let's dive in to see if (JYNT) missed or beat analyst's expectations.Rosalio Madrigal
Why The Joint Corp.’s (JYNT) Stock Is Up 5.01%
As of Wednesday, April 15, The Joint Corp.’s JYNT share price has surged by 5.01%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | JYNT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $115.2 | $1,825.3 | 23% |
|
| Shares Out (Mil) | 14.2 | 73.7 | 25% |
|
| Institutional Ownership | 68.4% | 86.9% | 42% |
|
| Float (Mil) | 6.5 | 56.1 | 14% |
|
| Beta | 1.05 | 0.75 | 63% |
|
| Avg Daily Volume (000s) | 92 | 522 | 35% |
|
| Price Change (52-week) |
(15.8%) | 80.0% | 36% |
|
| Growth | JYNT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (1.3%) | 10.6% | 14% |
|
| Net Income (5yr) | (26.1%) | (0.1%) | 16% |
|
| EPS (5yr) | (26.8%) | 3.1% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.3%) | (17.7%) | 44% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 1 | 2 | |
| Current EPS | $0.080 | $0.130 | $0.635 | |
| Month Ago EPS | $0.080 | $0.130 | $0.635 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | $0.085 | $0.277 | $0.433 | |
| Year/Year Chg | (544.4%) | (750.0%) | (1,600%) | |
| Financials | JYNT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $59 | $1,503 | 21% |
|
| Net Income (TTM) (Mil) | $4 | $26 | 42% |
|
| EPS (TTM) | $0.260 | $0.200 | 48% |
|
| Operating Cash Flow (TTM) (Mil) | $5 | $157 | 36% |
|
| Net Cash Flow (TTM) (Mil) | ($7) | $8 | 32% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $356 | 19% |
|
| Enterprise Value (Q1) (Mil) | $96 | $2,338 | 21% |
|
| Valuation | JYNT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.30 | 3.06 | 86% |
|
| P/E | 59.6 | 25.4 | 88% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | JYNT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 81.8% | 27.9% | 90% |
|
| Net Margin | 6.5% | 1.3% | 53% |
|
| ROA | 6.1% | 2.2% | 76% |
|
| ROE | 19.4% | 7.0% | 78% |
|
| Liabilities to Assets | 69.3% | 60.8% | 65% |
|
| F-Score | 9 | 5 | 98% |
|
The Joint Corp. did not pass any screens on 9/15/2026.
